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Copyright © 2010 JCBN Summary Inflammatory changes in the gastric mucosa are commonly observed in Japanese
patients with functional dyspepsia (FD). However, detailed data regarding the possible
association between the genetic factors of inflammation related molecules and FD are not
available. Toll like receptor 2 (TLR2) and mannan-binding lectin (MBL) protein play impor-
tant roles in the innate immune activation. We aimed to clarify the association between
common polymorphisms of TLR2 and MBL2 genes with FD in Japanese subjects. TLR2 −196
to  −174 del and MBL2 codon54 G/A polymorphisms were genotyped in 111 FD patients
according to Rome III criteria and 106 asymptomatic controls. Non-significant correlation was
found between TLR2 and MBL2 polymorphisms with FD. However, in Helicobacter pylori (H.
pylori) positives, we found significant inverse association between TLR2 −196 to −174 del
carrier and FD among H. pylori positive subjects (Adjusted odds ratio (OR) = 0.48, 95%
confidence interval (CI) = 0.23–0.996, p = 0.0488). We also found significant inverse association
between the same genotype with postprandial distress syndrome (PDS) among H. pylori
positive subjects (Adjusted OR = 0.22, 95% CI = 0.07–0.69, p = 0.0099). Our data suggest that
TLR2 −196 to −174 del carriers’s status but not MBL2 codon54 G/A is inversely related to
the risk with FD in H. pylori-infected subjects.
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Introduction
Functional dyspepsia (FD) is a common clinical syndrome
characterized by the presence of recurrent or chronic upper
abdominal symptoms, such as epigastric pain, early satiety,
and fullness, without anatomical or biochemical abnormality
identifiable by conventional diagnostic tests, including
upper gastrointestinal endoscopy [1]. Talley et al. [2] have
shown that up to 25% of the population experienced these
symptoms. FD is a heterogeneous condition indicated by
the variety of different pathophysiologic mechanisms that
have been demonstrated in this disorder [3], so FD does
not have a well pathophysiology. Gastrointestinal motor
abnormalities [4], altered visceral sensation [5] and psycho-
social factors [6] have thought to be essential in the patho-
physiology of FD. Recently, Locke et al. [7] reported familial
clustering of FD. In addition, it has been reported that G-
protein beta3 subunit gene polymorphism was associated
with FD [8, 9]. These facts suggest that the genetic factor
may play a significant role in the development of FD.
Helicobacter pylori (H. pylori) infection is a powerful
pathogenic factor and many studies have revealed a strongT. Tahara et al.
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association between this organism infection and gastric
disorders.  H. pylori infection usually leads to persistent
colonization and chronic gastric inflammation. According to
the Rome III criteria [10], H. pylori-infected patients, who
had some chronic or recurrent upper abdominal symptoms,
with neither ulceration nor erosion in gastroduodenal
mucosa by gastrointestinal endoscopy were diagnosed as
FD. This indicates that one of the FD subgroups may relate
to the gastric mucosal inflammation, although adult FD
patients frequently have motility abnormalities of the
stomach and upper small bowel including antral hypo-
motility and delayed gastric emptying [11–13].
Cells of the innate immune system sense and respond to
microbial products via the Toll-like receptors (TLRs). These
receptors recognize conserved molecular patterns that are
expressed by infectious agents. By this way, TLRs mediate
the activation of transcription factors, mainly nuclear factor-
kappa B (NF-κB) and proinflammatory cytokines resulting
in inflammation [14–18]. Among the TLRs, TLR2 has been
reported to be expressed in H. pylori infected gastric
epithelial cells [19]. It has been also reported that H. pylori
induced NF-κB activation and chemokine expression by
gastric epithelial cells through TLR2. HEK293 cells that
were stably transfected TLR2 resulted in extremely
enhanced expression of interleukin 8 (IL-8), MIP-3α and
GROα [20].
Mannan-binding lectin (MBL) protein, coded by the
MBL2 human gene, is also an important constituent of the
innate immune system. MBL initiates complement system
but also function as an opsonin [21, 22]. Research over the
past decade indicates that MBL provides a distinct third
pathway of complement activation, which is called “the
lectin pathway” and phylogenetic studies suggest that it may
have been the first such pathway to have evolved [23–25].
It was reported that mucosal expression of MBL was up-
regulated in H. pylori gastritis [26]. Furthermore, two recent
studies of possible association of MBL2 haplotype and the
susceptibility of H. pylori infection as well as the risk of
gastric cancer were reported [27, 28].
Recently we have shown that common polymorphisms of
TLR2 −196 to −174 del and MBL2 codon54 G/A (G54D)
are associated with susceptibility to gastric cancer [29, 30],
and the histological severity of H. pylori induced chronic
gastritis [31, 32]. We have also shown that MBL2 codon54
G/A (G54D) are also associated with certain phenotypes of
ulcerative colitis [33].
Since TLR2 and MBL may play a significant role in
innate immune responses against H. pylori infection. We
hypothesized that the polymorphisms of TLR2 and MBL2
gene may affect the severity of gastric mucosal inflamma-
tion by altering immune response against H. pylori, and
modify the susceptibility to FD.
In the present study, we investigated the prevalence of
TLR2 and MBL2 polymorphisms in patients with FD
diagnosed according to the Roma III criteria in a Japanese
population. We also wished to asses it’s effect on the
different subtypes of FD.
Materials and Methods
Study populations
Study populations were recruited from the subjects
attending the Endoscopy Center of Fujita Health University
Hospital from January 2006 to May 2008. This cohort is
partly recruited from recent study [34].
So this was described in the study population. All the
subjects underwent upper gastroscopy for their health check,
secondary complete check up of stomach cancer following
to barium X ray examination, or for the complaint of
abdominal discomfort. Subjects who have significant upper
gastrointestinal findings such as peptic ulcer disease, reflex
esophagitis and malignancies were excluded from this study.
Patients with malignancies in other organs, and had received
non-steroidal anti-inflammatory drugs, antibiotics, and H.
pylori eradication treatment were also excluded. Other
diseases were also excluded by face-to-face history and
physical examination including blood test, abdominal US
and ECG. According to the Roma III criteria, 111 dyspeptic
patients were identified as having a primary compliant of
either continuous or intermittent dyspepsia for 3 months,
onset at least 6 months before, predominantly located in
upper abdomen irrespective of using H2-receptor antago-
nists (H2RAS) or proton-pump inhibitors (PPIS). In 111
dyspeptic patients, 55 and 36 patients were diagnosed as
epigastric pain syndrome (EPS) and postprandial distress
syndrome (PDS) respectively.
Control subjects were recruited from the subjects who
were negative for significant upper gastrointestinal findings,
negative for dyspeptic symptom with in last 12 months and
negative for abnormal finding for history and physical
examinations. Finally, 106 asymptomatic subjects were
included as non-dyspeptic healthy controls. Their reason for
performing upper gastroscopy were, either for their health
check or, for secondary complete check up of stomach
cancer following to barium X ray examination. Those who
had received or proton-pump inhibitory drugs or H2RAS
during the 4 week were excluded from healthy controls. The
Ethics Committee of Fujita Health University School of
Medicine approved the protocol and written informed
consent was obtained from all of the subjects.
Detection of H. pylori infection
H. pylori infection was determined on the basis of rapid
urease test (RUT), serum antibody against H. pylori, and
histological assessment using endoscopic biopsy specimens.
During histological assessment, biopsy specimens wereTLR2 and MBL2 Polymorphisms in FD
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obtained from non-pathological mucosa of greater curvature
of the gastric antrum as well as upper corpus to avoid false-
negative of H. pylori infection as much as possible. Infection
was diagnosed when at least one of these 3 tests was positive.
Genotyping for TLR2 and MBL genes
Genomic DNA was extracted from non-neoplastic gastric
biopsies or peripheral blood using the standard phenol/
choloroform method. Polymorphisms at −196 to −174 del of
TLR2 were investigated by allele specific polymerase chain
reaction (PCR) method [29, 31]. PCR was performed in a
reaction volume of 25 μl containing 200 ng of genomic
DNA, 10 pmol of each primer, 200 ng of each dNTP and 0.6
units Taq DNA polymerase (Toyobo, Osaka, Japan). The
primers for TLR2 were as follows: forward 5'-cacggag-
gcagcgagaaa and reverse 5'-ctgggccgtgcaaagaag. The DNA
was denatured at 95°C for 5 min, followed by 35 cycles of
95°C for 30 s, 60°C for 40 s, and 72°C for 40 s. The final
extension step was prolonged to 7 min. PCR products were
visualized by electrophoresis on a 3.5% agarose gel by
staining with ethidium bromide. One single band at 286 bp
was judged as wild type (ins/ins), and a single 264 bp band
was judged as homozygous type (del/del), while heterozygous
type (ins/del) revealed two bands of 286 bp and 264 bp.
Polymorphisms at codon 54 G/A of MBL2 were investi-
gated by restriction enzyme digestion with Ban I of amplified
genomic DNA. PCR was performed in the same reaction
volume as TLR2. The primers for MBL were as follows:
forward 5'-ccttccctgagttttcacac-3' and reverse 5'-atcagtctcct-
catatcccc-3'. The DNA was denatured at 95°C for 5 min,
followed by 38 cycles of 95°C for 40 s, 55°C for 30 s, and
72°C for 40 s. The final extension step was prolonged to
7 min. The 298 bp PCR product (10 μl) was cleaved by Ban
I (New England Biolabs. Inc, Bevely, MA) in an appropriate
buffer at 37°C for 2 h.
PCR products were visualized by electrophoresis on a
3.0% agarose gel by staining with ethidium bromide. One
single band at 298 bp was judged as homozygous type
(54AA), and two bands of 195 bp and 103 bp was judged
as wild type (54GG), while heterozygous type (54GA)
revealed all three bands of 298 bp, 195 bp and 103 bp.
Statistical analysis
Hardy-Weinberg equilibrium of the TLR2 and MBL2
gene alleles in the control subjects were assessed by χ2
statistics. Differences of genotype frequencies among two
groups were determined by the two-sided Fisher’s exact test.
The odds ratio (OR) and 95% confidence interval (CI) were
also calculated. A probability value of less than 0.05 was
considered statistically significant in all analyses.
Results
Study population
A total of 111 FD patients including 55 EPS, 36 PDS, 26
other FD and 106 non-symptomatic control subjects partici-
pated in this study. The characteristics of the subjects are
summarized in Table 1. Age distribution was not signifi-
cantly different among those groups but female sex ratio was
significantly higher in patients with over all FD, EPS and
other FD than those of non-symptomatic control subjects.
Female sex ratio tended to be higher in PDS than those of
control. H. pylori infection positive ratio also tended to be
lower in EPS than those of control.
TLR2 and MBL genotypes
Polymorphisms at −196 to −174 del of TLR2 was geno-
typed for 110 FD and all control subjects, while poly-
morphisms at codon 54 G/A of MBL2 was genotyped for
all FD and 105 control subjects. The genotype distributions
of both genes in all subjects are shown in Table 2. The
frequency of TLR2 and MBL2 polymorphisms in the control
subjects did not deviate significantly from those expected
under the Hardy–Weinberg equilibrium (p = 0.91, 0.34). In
over all subjects, no significant differences were found
between both TLR2 and MBL2 genotypes frequencies and
FD. Non significant association was also found between
both TLR2 and MBL2 genotypes and subtypes of FD
Table 1. Characteristics of subjects
$; Control vs FD; p = 0.004, Controls vs EPS; p = 0.02, Controls vs PDS; p = 0.1, Controls vs Other FD;
p = 0.006. 
#; Control vs EPS; p = 0.07, statistical siginificant was assesed by χ2 test.
Note; Seven of FD patients were diagnosed as both EPS and PDS.
Variables (n) Sex (male:female)$ Age (mean ± SD)
H. pylori infection 
positive ratio (%)#
Controls (106) 64/42 60.9 ± 13.2 60.4
FD (111) 45/66 59.5 ± 13.6 53.2
EPS (55) 22/33 57.6 ± 14.3 45.5
PDS (36) 16/20 60.1 ± 13.6 47.2
Others (27) 8/19 62.7 ± 11.8 66.7T. Tahara et al.
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according to Rome III.
To further evaluate the effect of TLR2 and MBL2 poly-
morphisms on the susceptibility of FD, we investigated the
prevalence of both TLR2 and MBL genotypes in H. pylori
positive and negative subjects respectively (Table 3). In
the comparison of genotype frequency, we found significant
inverse association between TLR2 –196 to –174 del carrier
with FD among H. pylori positive subjects (ins/ins vs del
carriers; OR = 0.47, 95% CI = 0.23–0.98, p = 0.047). We
also found significant inverse association between the
same genotype with PDS among H. pylori positive subjects
(ins/ins vs del carrier; OR = 0.22, 95% CI = 0.07–0.70,
p = 0.01). In H. pylori negatives, such correlation was not
observed between the same genotype with the risk of FD
including its subtypes according to Rome III. Non significant
association was found between MBL2 genotype with the
susceptibility of FD in different H. pylori infection status.
Logistic regression analysis
As female sex ratio was significantly higher in the FD
patients than those of control, logistic regression analysis
with adjustment for sex was done in H. pylori positive cases.
We found that the significant association of the TLR2 −196
to −174 del carrier with FD and PDS was remained after
logistic regression analysis (FD: OR = 0.48, 95% CI = 0.23–
0.996, p = 0.0488, PDS: OR = 0.22, 95% CI = 0.07–0.60,
p = 0.0099; Table 3).
Discussion
Although the relationship between inflammation and
clinical presentation and treatment response is not well
established in FD, histological inflammation has been impli-
cated in the generation of gastrointestinal pain or discomfort
[35]. Because H. pylori infection is a mainly pathogenic
factor for gastric inflammation, it is suggested that inter-
individual differences of immune responses against H.
pylori may influence the severity of gastric inflammation
under the H. pylori infection and thus may modify the
dyspeptic symptoms [34, 36].
In the present study, we investigated the association of the
TLR2  −196 to −174 del and MBL2 codon54 G/A poly-
morphisms with FD. Although we failed to detect direct
association between polymorphisms of those two poly-
morphisms and susceptibility to FD in over all subjects, we
found that TLR2 −196 to −174 del carriers were signifi-
cantly associated with a lower risk for developing FD espe-
cially PDS in H. pylori-infected subjects by stratification
analysis.
It has been reported that TLR2 was expressed in H. pylori
infected gastric epithelial cells [19] and that H. pylori
induced NF-κB activation and chemokine expression by
gastric epithelial cells was enhanced through TLR2 [20].
Noguchi et al. reported that the −196 to −174 ins/ins and
ins/del genotypes of TLR2 was associated with higher
transcriptional activity than del/del genotype by the
luciferase reporter assay [37]. Recently, we have shown
that the −196 to −174 ins allele of TLR2 was associated
with histological severity of H. pylori induced gastric
mucosal atrophy and intestinal metaplasia especially in older
subjects, suggesting that the TLR2 genotype may modify the
severity of gastric mucosal inflammation in the long term
Table 2. TLR2 and MBL2 polymorphisms and risk of FD
Note: del carriers, del/del+ ins/del. A carriers, AA + GA. ND, not done.
One FD could not genotype for TLR2, and one control could not genotype for MBL2.
Statistical analysis was performed by two-sided Fisher’s exact test.
Variables n (%)
TLR2 genotype/n (%) OR (95% CI)p OR (95% CI)p
ins/ins ins/del del/del del/del vs others ins/ins vs del carriers
Controls (106) 42 (39.6) 49 (46.2) 15 (14.2) Reference Reference
Over all FD (110) 52 (47.3) 44 (40.0) 14 (12.7) 0.88 (0.40–1.94) 0.84 0.73 (0.43–1.26) 0.27
EPS (55) 22 (40.0) 26 (47.3) 7 (12.7) 0.88 (0.34–2.32) 1.00 0.98 (0.51–1.91) 1.00
PDS (36) 20 (55.6) 14 (38.9) 2 (5.5) 0.36 (0.08–1.64) 0.24 0.53 (0.24–1.13) 0.12
Others (26) 13 (50.0) 7 (26.9) 6 (23.1) 1.82 (0.63–5.27) 0.37 0.66 (0.28–1.55) 0.38
Variables n (%)
MBL2 genotype/n (%) OR (95% CI)p OR (95% CI)p
GG GA AA AA vs others GG vs A carriers
Controls (105) 62 (59.1) 35 (33.3) 8 (7.6) Reference Reference
Over all FD (111) 66 (59.5) 37 (33.3) 8 (7.2) 0.95 (0.34–2.63) 1.00 0.98 (0.57–1.69) 1.00
EPS (55) 30 (54.6) 19 (34.5) 6 (10.9) 1.50 (0.49–4.56) 0.56 1.20 (0.62–2.32) 0.62
PDS (36) 24 (66.7) 12 (33.3) 0 (0) ND 0.72 (0.33–1.60) 0.55
Others (27) 17 (63.0) 8 (29.6) 2 (7.4) 0.98 (0.20–4.91) 1.00 0.85 (0.35–2.03) 0.83TLR2 and MBL2 Polymorphisms in FD
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out come of H. pylori infection [31].
Although we did not investigate the effect of TLR2 poly-
morphism on TLR2 activity in human gastric epithelial
cells, it is possible that the polymorphism might have altered
the activity of TLR2 in the human gastric mucosa. Since
TLR2 plays important roles with respect to immunity
response against H. pylori, it may be reasonable for the −196
to −174 del allele, which is associated with lower transcrip-
tional activity to be associated with the reduced suscepti-
bility to FD in H. pylori infected subjects.
We have also shown that the same genotype is associated
with reduced susceptibility to H. pylori positive PDS
according to Rome III. Holtmann et al. have reported that
H. pylori positive individuals are as likely to have symptoms
of bloating and early satiety as symptoms likely to PDS
[38]. On the other hand, it has been also reported that the
abdominal pain score and indigestion score of the Gastro-
intestinal Symptoms Rating Scale are correlated to histo-
logical gastric mucosal atrophy and significantly decreased
after eradication therapy in H. pylori-infected patients with
ulcer-like FD [39, 40].
Since our data showed that H. pylori-infected patients
with TLR2 −196 to −174 del carriers held lower risk of
developing dyspeptic symptoms, especially PDS according
to Rome III, H. pylori eradication may be recommended
to other genotypes (homozygous TLR2 −196 to −174 ins)
initially for prevention or for treatment of dyspeptic
symptoms.
However, the association between H. pylori positive FD
and TLR2 genotype is obtained from small samples, and the
Table 3. TLR2 and MBL2 polymorphisms and risk of FD in different H. pylori infection status
Note: del carriers, del/del+ ins/del. A carriers, AA + GA. ND, not done.
One FD could not genotype for TLR2, and one control could not genotype for MBL2.
Statistical analysis was performed by two-sided Fisher’s exact test.
#; Sex adjusted OR (95% CI)p = 0.48 (0.23–0.996) 0.0488.
$; Sex adjusted OR (95% CI)p = 0.22 (0.07–0.60) 0.0099.
Variables n (%)
TLR2 genotype/n (%) OR (95% CI)p OR (95% CI)p
ins/ins ins/del del/del del/del vs others ins/ins vs del carriers
H. pylori(–)
Controls (42) 20 18 4 Reference Reference
Over all FD (51) 21 21 9 2.04 (0.58–7.15) 0.37 1.30 (0.57–2.96) 0.67
EPS (30) 12 12 6 2.38 (0.61–9.29) 0.30 1.36 (0.53–3.52) 0.63
PDS (19) 8 9 2 1.12 (0.19–6.70) 1.00 1.25 (0.42–3.73) 0.78
Others (8) 3 3 2 3.17 (0.4–21.24) 0.24 1.52 (0.32–7.17) 0.71
H. pylori(+)
Controls (64) 22 31 11 Reference Reference
Over all FD (59) 31 23 5 0.45 (0.15–1.37) 0.19 0.47 (0.23–0.98) 0.047#
EPS (25) 10 14 1 0.20 (0.02–1.64) 0.17 0.79 (0.30–2.04) 0.63
PDS (17) 12 5 0 ND 0.22 (0.07–0.70) 0.01$
Others (18) 10 4 4 1.38 (0.38–4.99) 0.73 0.42 (0.14–1.21) 0.17
Variables n (%)
MBL2 genotype/n (%) OR (95% CI)p OR (95% CI)p
GG GA AA AA vs others GG vs A carriers
H. pylori(–)
Controls (41) 21 15 5 Reference Reference
Over all FD (52) 25 23 4 0.60 (0.15–2.39) 0.50 1.13 (0.50–2.57) 0.84
EPS (30) 12 15 3 0.80 (0.18–3.64) 1.00 1.58 (0.61–4.09) 0.47
PDS (19) 12 7 0 ND 0.61 (0.20–1.87) 0.42
Others (9) 5 3 1 0.90 (0.09–8.80) 1.00 0.84 (0.20–3.58) 1.00
H. pylori(+)
Controls (64) 41 20 3 Reference Reference
Over all FD (59) 41 14 4 1.48 (0.32–6.90) 0.71 0.78 (0.37–1.66) 0.57
EPS (25) 18 4 3 2.77 (0.52–14.77) 0.34 0.69 (0.25–1.91) 0.62
PDS (17) 12 5 0 ND 0.74 (0.23–2.37) 0.78
Others (18) 12 5 1 1.20 (0.12–12.25) 1.00 0.89 (0.30–2.69) 1.00T. Tahara et al.
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type 2 error could not be excluded. This is a major limitation
of our study and whether the TLR2 genotype may associated
with Rome III subtypes needs further evaluation.
MBL is also an important constituent of the innate immune
system in H. pylori infection. Codon 54AA genotype and A
allele of MBL2 gene, which is associated with lower plasma
concentration of MBL protein [41] are associated with
gastric cancer [30] and histological severity of H. pylori
induced gastric mucosal atrophy [32].
However, we did not find any association between MBL2
genotypes and FD. MBL2 polymorphism may be associated
with gastric carcinogenesis and premalignant condition but
not with the dyspeptic symptoms.
In conclusion, we have shown that TLR2 −196 to −174
del carriers’s status but not MBL2 codon54 G/A is inversely
related to the susceptibility to FD especially PDS in H.
pylori-infected subjects.
Our data suggest that polymorphisms modulating the
innate immune activations are associated with the FD under
the influence of H. pylori infection. Our data also indicates
the possible role of gastric mucosal inflammation in the
pathophysiology of some subgroup of FD. Our study show
that further longitudinal genetic studies will be needed in a
larger, and ethnically diverse population to resolve the
impact of the genetic polymorphisms of molecules associated
with innate immune responses in the susceptibility to FD.
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